Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: A comparative flow cytometric study

British Journal of Dermatology

Volumn 135, Issue 3, 1996, Pages 379-384

  Glade, C P ^a   Van Erp, P E J ^a   Van De Kerkhof, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; CALCIPOTRIOL; CLOBETASONE BUTYRATE; DNA; KERATIN; VIMENTIN;

ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDERMIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

EID: 0029840873     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb01499.x     Document Type: Article

References (27)

1. van de Kerkhof PCM, Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br J Dermatol 1995; 132: 675-82.
2. 3 analogue MC 903 on cell proliferation and differentiation in vitro and calcium metabolism in vivo. Biochem Pharmacol 1988; 37: 889-95.
3. 3 analogue, stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 1990; 282: 164-7.
4. 3 and its analogue calcipotriol on epidermal cells. Br J Dermatol 1993; 130: 424-31.
5. 3 and a novel vitamin D analogue MC903 are potent inhibitors of human interleukin 1 in vitro. Immunol Lett 1988; 17: 361-6.
6. 3 analogue MC903 and betamethasone. Br J Dermatol 1990; 123: 291-5.
7. 3 analogue MC903. Br J Dermatol 1990; 122: 284 (Abstr.)
8. Berth-Jones J, Fletcher A, Hutchinson PE. Epidermal cytokeratin and immunocyte responses during treatment of psoriasis with calcipotriol and betamethasone valerate. Br J Dermatol 1992; 126: 356-61.
9. 3 analogue MC903: modulations and interrelations. Br J Dermatol 1991; 124: 221-9.
10. Oxholm A, Oxholm P, Staberg B, Bendtzen K. Expression of interleukin-6-like molecules and tumour necrosis factor after topical treatment of psoriasis with a new vitamin D analogue (MC903), Acta Derm Venereol (Stockh) 1989; 69: 385-90.
11. 3 derivative MC903 in psoriasis: influence on cellular infiltrate, Langerhans cells and keratinocyte (KC) markers. J Invest Dermatol 1989; 93: 310 (Abstr.)
12. Mallett RB, Coulson III, Purkis PE et al. An immunohistochemical analysis of the changes in the immune infiltrate and keratin expression in psoriasis treated with calcipotriol compared with betamethasone ointment. Br J Dermatol 1990; 123: 837 (Abstr.)
13. Grossman RM, Thivolet J, Claudy A et al. A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: Results of a multicenter placebo-controlled study. J Am Acad Dermatol 1994; 31: 68-74.
14. Kragballe K. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903). Arch Dermatol 1989; 125: 1647-52.
15. Dubertret L, Wallach D, Souteyrand P et al. Efficacy and safety of calcipotriol (MC903) ointment in psoriasis vulgaris. J Am Acad Dermatol 1995; 27: 983-8.
16. Kragballe K, Gjertsen BT, de Hoop D et al. Double-blind. right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991; 337: 193-6.
17. Cunliffe WJ, Berth-Jones J, Claudy A et al. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992; 26: 736-43.
18. Berth-Jones J, Chu AC, Dodd WAH et al. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 1992; 127: 266-71.
19. 3 und seine Analoge in der Dermatologie. Z Hautkr 1994; 69: 219-26.
20. van Hooijdonk CAEM, Glade CP, van Erp PEJ. TO-PRO-3 iodide, a novel HeNe laser-excitable DNA stain as an alternative for propidium iodide in multiparameter flow cytometry. Cytometry 1994; 17: 185-9.
21. 3: a Multiparameter flow cytometrical analysis of epidermal growth, differentiation and inflammation. Acta Derm Venerol (Stockh) 1995; 75: 381-5.
22. Bauer FW, Boezeman JBM, van Engelen L et al. Monoclonal antibodies for epidermal population analysis. J Invest Dermatol 1986; 87: 72-5.
23. Ramackers FCM, Puts JJ, Moesker O et al. Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview. Histochem J 1983; 15: 691-713.
24. Leigh IM, Purkis PE, Whitehead P, Lane EB. Monospecific monoclonal antibodies to keratin I carboxy terminal (synthetic peptide) and to keratin 10 as markers of epidermal differentiation. Br J Dermatol 1993; 129: 110-19.
25. Bauer FW, Boezeman JBM. Flow cytometric methods in human skin with respect to cell cycle kinetics. In: Psoriasis: Cell Proliferation (Wright NB, Camplejohn RS, eds). Edinburgh: Churchill Livingstone, 1983; 104-16.
26. Glade CP, Seegers BAMPA, Meulen EFJ et al. Multiparameter flow cytometric characterization of epidermal cell suspensions prepared from normal and hyperproliferative skin using an optimized thermolysin trypsin protocol. Anch Dermatol Res 1996; 288: 203-10.
27. 1 applications analysed by three-colour flow cytometry. Acta Derm Venereol (Stockh) 1995; 25: 437-40.